edentulous patients. [1][2][3] Osseointegration, defined as binding to the surrounding bone, is the fundamental requirement for successful implant surgery. [4,5] Firstgeneration osseointegrated titanium implants had smooth turned surfaces, requiring approximately six months for osseointegration to be completed before loading. [4] To speed up and improve the quality of osseointegration, various treatment methods for the titanium implant surface, such as sandblasting and acidetching (SLA), have been investigated. [5][6][7] As reported by Buser et al., SLA implants, owing to their roughened surface, showed improved bone responses compared to those with turned surfaces. [8] However, a rough surface is disadvantageous when exposed above bone level because of periimplantitis. According to the study done in 2006 by Berglundh et al., the roughened surface of the implant created by SLA treatment expedited the progression of peri-implantitis compared to a polished surface because a rough surface is favorable for plaque acquisition. [9] Graphene oxide (GO) is an oxidized form of graphene, a nanomaterial made of sp 2 hybridized carbon atoms arranged in a hexagonal lattice. Since the first report on graphene in 2004 by Graphene, a nanomaterial made of sp 2 hybridized carbon atoms, has recently been investigated as a novel surface treatment for promoting osseointegration. This study aims to evaluate the biological effects of graphene oxide (GO) on turned and sandblasted, large-grit, and acid-etched (SLA) titanium surfaces. In vitro, bone marrow stromal cells (BMSCs) and human gingival fibroblasts (HGFs) are seeded onto titanium discs, whose surfaces have been treated in four different ways (SLA and/or GO), to observe its effects on cellular responses such as adhesion, proliferation and differentiation. In vivo, a rabbit tibia model is used to observe the effects of the four surface treatments on osseointegration of screw-shaped titanium implants. The bone-to-implant contact is analyzed using light microscopic histomorphometry. GO significantly promotes the viability, proliferation and osteoblast differentiation of BMSCs, and it enhances the attachment and proliferation of HGFs. SLA and GO treatment of implant surfaces results in significant improvement of osseointegration in vivo. Physicochemical modification of the titanium surface by SLA treatment and GO coating stimulates osteogenic activities of mesenchymal stem cells and improves biocompatibility to connective tissue cells, leading to enhancement of bone healing at the bone-implant interface.